Thank you for attending the ASCEPT-APSA 2020 Joint Virtual Scientific Meeting.
On behalf of the Organising Committee, we thank you for attending the ASCEPT- APSA 2020 Joint Virtual Scientific Meeting on 24 – 26 November 2020.
The theme for this meeting was: Global solutions for global challenges
We hope you found the meeting both professionally and personally rewarding and look forward to seeing you next year at the 2021 meeting.
All presentation recordings have now been uploaded to the virtual meeting portal and will be available for viewing up until Friday 11 December 2020.
Thank you for your continued interest and your support of both ASCEPT and APSA.
ASCEPT-APSA 2020 Organising Committee
| Dr Dan Wright ASCEPT Co-chair |
Dr Jonathan Penm APSA Co-chair |
 |
 |
Who should attend:
The conference is open to members and non-members from related disciplines, and is relevant for:
o Scientists from academia and industry who are involved in drug discovery, drug formulation and drug delivery research and development
o Researchers in the fields of neuropharmacology, cardiovascular pharmacology, respiratory and inflammatory disease pharmacology, urogenital and gastrointestinal pharmacology, toxicology, pharmacogenomics and pharmacoepidemiology.
o Regulatory and clinical scientists involved in bioavailability and bioequivalence study design and assessment, preparation and review of regulatory dossiers
o Researchers and clinicians in the clinical and practice areas of pharmacy
o Academics and researchers and with an interest in pharmacy education
o Government agencies involved in chemical safety assessment and registration
o Medical practitioners such as clinical pharmacologists, clinical toxicologists, cardiologists and general physicians.
o Students and postdoctoral fellows from all areas of pharmacology, toxicology, pharmacy practice, pharmacy education and pharmaceutical sciences.